Allicin Inhibited Staphylococcus Aureus -Induced Mastitis by Reducing Lipid Raft Stability Via LxRα in Mice.

Yu Chen,Ying Wang,Mei Yang,Meng-yao Guo
DOI: https://doi.org/10.1021/acs.jafc.9b04378
IF: 6.1
2019-01-01
Journal of Agricultural and Food Chemistry
Abstract:Mastitis, inflammation of the mammary gland, occurs in both humans and animals. Staphylococcus aureus is the most common infectious bacterial pathogen associated with mastitis. We investigated the effects of allicin on S. aureus-induced mastitis in mice. Pathological histology revealed that allicin inhibited S. aureus-induced pathological damage and myeloperoxidase activity in mammary tissues. Enzyme-linked immunosorbent assays demonstrated that allicin reduced the production of IL-1 beta and TNF-alpha as well as inhibited the NF-kappa B and mitogen-activated protein kinase pathway by reducing phosphorylation of p65, I kappa B alpha, p38, JNK, and ERK. Western blotting revealed that allicin reduced TLR2 and TLR6 expression in mammary tissues and cells but not in HEK293 cells. The lipid raft content was reduced by allicin, which inhibited signaling downstream of TLR2 and TLR6. Liver X receptor alpha (LXR alpha) luciferase reporter assays and LXR alpha interference experiments showed that allicin improved the LXR alpha activity and adenosine 5'-triphosphate-binding cassette G and A1 (ABCG and ABCA1) expression, thereby reducing the cholesterol level, lipid raft formation, and downstream TLR2 and TLR6 pathway activity. These results demonstrated that allicin exerted anti-inflammatory effects against S. aureus mastitis by improving the LXR alpha activity and reducing lipid raft formation.
What problem does this paper attempt to address?